GCIA
OYST

Gabelli & Co Investment Advisers’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio OYST Stock Details OYST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-170,250
Closed -$1.9M – 334
2022
Q4 		$1.9M Buy
+170,250
New +$1.65M 0.41% 49

Other funds holding OYST

HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Gabelli & Co Investment Advisers's OYST Position: Q1 2023 in Review

Gabelli & Co Investment Advisers sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q1 2023, closing a stake of 170,250 shares — an estimated $1.9M sold.

Gabelli & Co Investment Advisers first reported a position in OYST in Q4 2022 and held it in 1 quarter. The position peaked at $1.9M in Q4 2022. 1 fund tracked by Wall St. Rank holds OYST as of Q1 2023.

  • Gabelli & Co Investment Advisers reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Gabelli & Co Investment Advisers sold 170,250 Oyster Point Pharma, Inc. Common Stock shares in Q1 2023, an estimated $1.9M.
  • Gabelli & Co Investment Advisers first reported a position in Oyster Point Pharma, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
  • Gabelli & Co Investment Advisers's Oyster Point Pharma, Inc. Common Stock position peaked at $1.9M in Q4 2022.
  • 1 fund tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q1 2023.

Based on Gabelli & Co Investment Advisers's 13F filing for Q1 2023, filed 12 May 2023.